Northern Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-572,845
| Closed | -$86.6M | – | 4800 |
|
2022
Q3 | $86.6M | Sell |
572,845
-1,925
| -0.3% | -$291K | 0.02% | 594 |
|
2022
Q2 | $83.7M | Buy |
574,770
+48,218
| +9% | +$7.03M | 0.02% | 622 |
|
2022
Q1 | $62.4M | Sell |
526,552
-54,922
| -9% | -$6.51M | 0.01% | 881 |
|
2021
Q4 | $80.1M | Buy |
581,474
+25,281
| +5% | +$3.48M | 0.01% | 778 |
|
2021
Q3 | $77.3M | Sell |
556,193
-3,672
| -0.7% | -$510K | 0.01% | 795 |
|
2021
Q2 | $54.4M | Buy |
559,865
+19,323
| +4% | +$1.88M | 0.01% | 1066 |
|
2021
Q1 | $36.9M | Sell |
540,542
-18,432
| -3% | -$1.26M | 0.01% | 1361 |
|
2020
Q4 | $47.9M | Sell |
558,974
-12,145
| -2% | -$1.04M | 0.01% | 1107 |
|
2020
Q3 | $37.1M | Sell |
571,119
-15,497
| -3% | -$1.01M | 0.01% | 1119 |
|
2020
Q2 | $42.9M | Buy |
586,616
+61,824
| +12% | +$4.52M | 0.01% | 1006 |
|
2020
Q1 | $17.9M | Buy |
524,792
+49,949
| +11% | +$1.7M | 0.01% | 1485 |
|
2019
Q4 | $25.9M | Sell |
474,843
-15,006
| -3% | -$817K | 0.01% | 1525 |
|
2019
Q3 | $20.4M | Buy |
489,849
+91,128
| +23% | +$3.8M | ﹤0.01% | 1679 |
|
2019
Q2 | $17.5M | Buy |
398,721
+13,613
| +4% | +$596K | ﹤0.01% | 1782 |
|
2019
Q1 | $19.8M | Buy |
385,108
+39,475
| +11% | +$2.03M | ﹤0.01% | 1698 |
|
2018
Q4 | $12.8M | Sell |
345,633
-636
| -0.2% | -$23.5K | ﹤0.01% | 1904 |
|
2018
Q3 | $13M | Buy |
346,269
+22,346
| +7% | +$839K | ﹤0.01% | 2093 |
|
2018
Q2 | $12.8M | Buy |
323,923
+20,093
| +7% | +$794K | ﹤0.01% | 2105 |
|
2018
Q1 | $7.83M | Buy |
303,830
+186,274
| +158% | +$4.8M | ﹤0.01% | 2326 |
|
2017
Q4 | $3.17M | Buy |
117,556
+148
| +0.1% | +$3.99K | ﹤0.01% | 2872 |
|
2017
Q3 | $4.39M | Buy |
117,408
+4,381
| +4% | +$164K | ﹤0.01% | 2706 |
|
2017
Q2 | $2.83M | Buy |
+113,027
| New | +$2.83M | ﹤0.01% | 2953 |
|